ARCHIVES

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

This article is from The Cancer Letter archive.

Vol. 19 No. 14 | April 2, 1993

Download PDF Visit The Full Archive

Related Articles

Physician Bonus Denied Some Agencies; NIH Status Unsure

January 18, 1991

Illinois Cancer Center Closes Following Veto of State Funds; Was First Consortium Center

December 11, 1992

New Grant Program in Physical Activity

March 28, 2003

Bristol-Myers Survey Predicts Year 2000 Survival of 66%

April 3, 1987

City of Hope Selects Michael Friedman As President, CEO

May 16, 2003

In Brief: Robert Bast Succeeds Singleton As Director Of Duke Cancer Center; Robert Bell Deputy

August 14, 1987